Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when HALO files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: HALO HALOZYME THERAPEUTICS, INC. 8-K

Halozyme COO Cortney Caudill departs amid senior management restructuring

Filed July 2, 2026 · Period ending June 30, 2026 · ~1 min read

1 key change 1 section

Key Changes

  • medium

    COO Cortney Caudill departed June 30, 2026 as part of a senior management restructuring. No transition details or replacement announced.

Summary

Halozyme announced that Cortney Caudill departed as Senior Vice President and Chief Operating Officer effective June 30, 2026. The company characterized the departure as part of a broader update to its senior management structure, but provided no details about the circumstances, transition arrangements, or plans to fill the COO role. For retail holders, an unexplained COO departure during a restructuring raises questions about operational continuity and strategic direction.

The lack of detail about succession planning or the scope of the restructuring leaves investors without visibility into how critical operating functions will be managed. Watch for follow-on disclosures about the restructuring's scope, any additional leadership changes, and how COO responsibilities will be redistributed.

Section-by-Section Diff

Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation

~100 words

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.

1 Added
Added COO departure medium

Added in current filing · verify on EDGAR →

On June 30, 2026, Halozyme Therapeutics, Inc. (the “Company”) announced an update to its senior management structure. The company also announced the departure of Cortney Caudill as the Company’s Senior Vice President, Chief Operating Officer.

Halozyme disclosed that Cortney Caudill departed as Senior Vice President and Chief Operating Officer effective June 30, 2026. The departure is described as part of a broader senior management restructuring. No details about the circumstances of the departure, transition plans, or replacement were provided.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Jul 8, 2026 · How we verify